MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.bbmt.2019.08.020

Медицинская библиотека · Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2019

Partial T Cell-Depleted Peripheral Blood Stem Cell Transplantation from HLA-Identical Sibling Donors for Patients with Severe Aplastic Anemia.

Sanz Jaime, Moscardó Federico, Montoro Juan, Cano Isabel, Guerreiro Manuel, Dasí María A, Solves Pilar, Lorenzo Ignacio, Gómez-Segui Inés, Montesinos Pau, Mora Elvira, Arnao Mario, Sempere Amparo, Jarque Isidro, Carretero Carlos, Senent Leonor, Vicente Ana, Andreu Rafael, Luna Irene, Balaguer-Roselló Aitana, Carpio Nelly, Sanz Guillermo F, Sanz Miguel A, Piñana José L

Клиническое исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

We analyzed the outcomes of 26 consecutive patients with acquired severe aplastic anemia (SAA) undergoing peripheral blood stem cell transplantation (PBSCT) with partial ex vivo T cell depletion with a targeted T cell dose from HLA-identical sibling donors. The median patient age was 37 years (range, 3 to 63 years). Four patients with uncontrolled pneumonia at the time of transplantation died, on days +1, +2, +21, and +26. All evaluable patients engrafted, with a median time to neutrophil recovery of 11 days (range, 10 to 14 days) and a median time to platelet recovery of 19 days (range, 8 to 53 days). Two patients had transient grade I acute graft-versus-host disease (GVHD) with skin involvement, but no patients developed grade II-IV acute GVHD. Two patients had mild skin chronic GVHD, and 1 patient had moderate chronic GVHD with ocular involvement. No relapse was observed after a median follow-up of 114 months (range, 4 to 233 months). The overall cumulative incidence of TRM at 10 years was 19%, whereas it was 5% for those with a Karnofsky Performance Status (KPS) score >60 at the time of transplantation. Disease-free survival, overall survival, and GVHD and relapse-free survival at 10 years were 81%, 81%, and 80%, respectively, for all patients and 95%, 95%, and 90%, respectively, for patients with a KPS score >60 at transplantation. Our data indicate that PBSCT with partial ex vivo T cell-depleted targeted cell dose grafts from an HLA-identical sibling donor is a feasible, safe, and effective approach to reduce GVHD and cure patients with SAA.

Для цитирования: Sanz Jaime, Moscardó Federico, Montoro Juan, Cano Isabel, Guerreiro Manuel, Dasí María A, Solves Pilar, Lorenzo Ignacio, Gómez-Segui Inés, Montesinos Pau, Mora Elvira, Arnao Mario, Sempere Amparo, Jarque Isidro, Carretero Carlos, Senent Leonor, Vicente Ana, Andreu Rafael, Luna Irene, Balaguer-Roselló Aitana, Carpio Nelly, Sanz Guillermo F, Sanz Miguel A, Piñana José L. Partial T Cell-Depleted Peripheral Blood Stem Cell Transplantation from HLA-Identical Sibling Donors for Patients with Severe Aplastic Anemia.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019. DOI: 10.1016/j.bbmt.2019.08.020.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.